Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Medical Robot Maker Cyberdyne Doubles in Tokyo Trading Debut

March 26 (Bloomberg) -- Cyberdyne Inc., the maker of exoskeleton suits that help in rehabilitation, more than doubled on its Tokyo trading debut, the second-best first day performance among Japan initial public offerings this year.

Cyberdyne surged 159 percent to close at 9,600 yen on the Tokyo Stock Exchange’s Mothers market, compared with its IPO price of 3,700 yen. EnBio Holdings Inc. gained 178 percent on its first day of trading.

Aging populations and concern over rising health costs are spurring companies in the U.S., Europe and Japan to develop bionic suits and robotic devices that may some day save labor and help the physically disabled and elderly care for themselves. People above the age of 65 will make up 40 percent of Japan’s population by 2060, compared with about 25 percent currently, encouraging companies to invest in products for the elderly.

Spun off as a start up from the University of Tsukuba in 2004, Cyberdyne began trading after a 7.8 billion yen ($76 million) IPO. The company plans to invest in expanding the reach of its exoskeleton suit called HAL, or Hybrid Assistive Limb, globally.

To contact the reporter on this story: Anjali Cordeiro in Hong Kong at acordeiro2@bloomberg.net

To contact the editors responsible for this story: Anjali Cordeiro at acordeiro2@bloomberg.net Suresh Seshadri

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.